UGT1A1*28 genotype–driven phase II study of irinotecan and doxifluridine (5'-DFUR, an intermediate form of capecitabine) for metastatic colorectal cancer. Correlation of tumor regression grade (TRG), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results